Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P W Gold

Showing results (1-10 of 321) with videos related to

Pageof 33
Sort By:
Molecular Psychiatry|December 10, 2014
The organization of the stress system and its dysregulation in depressive illnessP W Gold
Molecular Psychiatry|August 24, 2013
Evidence that stress per se has a role in the precipitation and natural history of depressive illnessP W Gold
Biological Psychiatry|August 1, 1988
Stress-responsive neuromodulatorsP W Gold
General Hospital Psychiatry|December 1, 1983
Interruption of recurrent ventricular fibrillation by psychiatric interventionP Reich, P W Gold
Annals of the New York Academy of Sciences|June 18, 1998
Pathophysiologic and somatic investigations of hypothalamic-pituitary-adrenal axis activation in patients with depressionD Michelson, P W Gold
Bailliere'S Clinical Endocrinology and Metabolism|March 1, 1991
Role of corticotrophin releasing hormone 41 in depressive illnessJ Licinio, P W Gold
Neuropeptides|January 1, 1991
Corticotropin releasing hormone produces profound anorexigenic effects in the rhesus monkeyJ R Glowa, P W Gold
Proceedings of the Association of American Physicians|January 20, 1999
The endocrinology of melancholic and atypical depression: relation to neurocircuitry and somatic consequencesP W Gold, G P Chrousos
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1988
Oxytocin: neurobiologic considerations and their implications for affective illnessM A Demitrack, P W Gold
Psychoneuroendocrinology|January 1, 1985
Clinical studies with corticotropin releasing factor: implications for the diagnosis and pathophysiology of depression, Cushing's disease, and adrenal insufficiencyP W Gold, G P Chrousos
Pageof 33

Showing results (1-10 of 321) with videos related to

Sort By:
Pageof 33
Molecular Psychiatry|December 10, 2014
The organization of the stress system and its dysregulation in depressive illnessP W Gold
Molecular Psychiatry|August 24, 2013
Evidence that stress per se has a role in the precipitation and natural history of depressive illnessP W Gold
Biological Psychiatry|August 1, 1988
Stress-responsive neuromodulatorsP W Gold
General Hospital Psychiatry|December 1, 1983
Interruption of recurrent ventricular fibrillation by psychiatric interventionP Reich, P W Gold
Annals of the New York Academy of Sciences|June 18, 1998
Pathophysiologic and somatic investigations of hypothalamic-pituitary-adrenal axis activation in patients with depressionD Michelson, P W Gold
Bailliere'S Clinical Endocrinology and Metabolism|March 1, 1991
Role of corticotrophin releasing hormone 41 in depressive illnessJ Licinio, P W Gold
Neuropeptides|January 1, 1991
Corticotropin releasing hormone produces profound anorexigenic effects in the rhesus monkeyJ R Glowa, P W Gold
Proceedings of the Association of American Physicians|January 20, 1999
The endocrinology of melancholic and atypical depression: relation to neurocircuitry and somatic consequencesP W Gold, G P Chrousos
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1988
Oxytocin: neurobiologic considerations and their implications for affective illnessM A Demitrack, P W Gold
Psychoneuroendocrinology|January 1, 1985
Clinical studies with corticotropin releasing factor: implications for the diagnosis and pathophysiology of depression, Cushing's disease, and adrenal insufficiencyP W Gold, G P Chrousos
Pageof 33